Duzalta 30mg Capsules

Duzalta 30mg Capsules contain the active ingredient Duloxetine, which belongs to the class of medications known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It is prescribed for the treatment of various mental health conditions and chronic pain disorders.

Uses:

Duzalta 30mg Capsules are primarily prescribed for the following conditions:

• Major Depressive Disorder (MDD): A mood disorder characterized by persistent feelings of sadness and loss of interest in daily activities.
• Generalized Anxiety Disorder (GAD): Excessive and persistent worry and anxiety about everyday situations.
• Diabetic Peripheral Neuropathic Pain (DPNP): Pain associated with nerve damage in individuals with diabetes.
• Fibromyalgia: A chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas.
• Chronic Musculoskeletal Pain: Non-specific pain associated with conditions affecting the muscles and skeletal system.

Mechanism of Action:

Duloxetine works by increasing the levels of serotonin and norepinephrine in the brain. These neurotransmitters play a role in mood regulation and pain perception.

Administration:

Take the capsule orally, with or without food, as directed by your healthcare provider. Follow the prescribed dosage and duration of treatment.

Side Effects:

Common side effects may include nausea, dry mouth, drowsiness, and constipation. Serious side effects may include changes in blood pressure, liver problems, and serotonin syndrome. Report any unusual or severe side effects to your healthcare provider.

Precautions:

• Inform your healthcare provider about any pre-existing medical conditions, especially liver or kidney problems.
• Disclose all medications, including prescription and over-the-counter drugs, as well as any herbal supplements, to avoid potential interactions.
• Monitor for signs of suicidal thoughts, especially in individuals under the age of 24.

When Not to Use:

Duzalta 30mg Capsules may not be suitable for use in individuals with known hypersensitivity or allergy to Duloxetine or any components of the capsules. It is also contraindicated in individuals taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing them.